Get in touch today 206.598.4100 or

Schedule an Appointment

Open Clinical Trials

We have many clinical trials open that involve radiation therapy for cancer open for enrollment of patients. The trials for specific types of cancer are listed below.

 

About Clinical Trials

For some patients, taking part in a clinical trial may be the best treatment choice. Clinical trials are done to find out if new cancer treatments are effective, safe and better than the standard treatment.  Many of today’s standard treatments for cancer are based on earlier clinical trials. Patients who take part in a clinical trial may receive the standard treatment or be among the first to receive a new treatment. Patients who take part in clinical trials also help improve the way cancer will be treated in the future. Even when clinical trials do not lead to effective new treatments, they often answer important questions and improve the treatment of cancer.

Brain and Spine Tumors

RG1123131

DebioPharm: A Phase 1/2 open-label study of Debio 0123 in combination with temozolomide in adult participants with recurrent or progressive glioblastoma and of Debio 0123 in combination with temozolomide and radiotherapy in adult participants with newly diagnosed glioblastoma

Read More at ClinicalTrials.gov

Investigators: Jonathan Yang, MD, PhD

Breast Cancer

Gastrointestinal Cancers

Genitourinary Cancers

RG1121714

DASL-HiCaP: Darolutamide Augments Standard Therapy for Localised Very High-Risk Cancer of the Prostate (ANZUP1801). A randomised phase 3 double-blind, placebo-controlled trial of adding darolutamide to androgen deprivation therapy and definitive or salvage radiation in very high risk, clinically localised prostate cancer.

Read More at ClinicalTrials.gov

RG1004762/S1802

Phase III Randomized Trial of Standard Systemic Therapy (SST) Versus Standard Systemic Therapy Plus Definitive Treatment (Surgery or Radiation) of the Primary Tumor in Metastatic Prostate Cancer

Read More at ClinicalTrials.gov

Head and Neck Cancers

RG1123073/HN009

Randomized Phase II/III Trial of Radiation With High-Dose Cisplatin (100Mg/M2 ) Every Three Weeks Versus Radiation With Low-Dose Weekly Cisplatin (30Mg/M2) For Patients With Locoregionally Advanced Squamous Cell Carcinoma Of the Head and Neck (SCCHN)

Read More at ClinicalTrials.gov

RG1121804/CC10819

A Double Blind, Placebo Controlled Dose Range Finding Study to Assess the Safety, Pharmacokinetics, and Efficacy of TEMPOL for the Reduction of Severe Mucositis in Head and Neck Cancer Patients Undergoing Combined Radio- and Chemotherapy

Read More at ClinicalTrials.gov

Investigators: Jay Liao, MD

Lung and Thoracic Cancers

RG1006225/CC10356

A Phase III, Randomized, Placebo-controlled, Double blind, Multi-center, International Study of Durvalumab Following SBRT for the Treatment of Patients with unresected Stage I/II, lymph-node negative Non-small Cell Lung Cancer (PACIFIC4/RTOG-3515)

Read More at ClinicalTrials.gov

Investigators: Jing Zeng, MD

Other